TherapeuticsMD earnings missed by $0.17, revenue was in line with estimates

  • Investing.com
TherapeuticsMD earnings missed by $0.17, revenue was in line with estimates

Investing.com - TherapeuticsMD (NASDAQ: TXMD ) reported second quarter EPS of $-0.2400, $0.17 worse than the analyst estimate of $-0.0700. Revenue for the quarter came in at $500K versus the consensus estimate of $500K.

TherapeuticsMD's stock price closed at $3.9600. It is down -6.6000% in the last 3 months and down -56.7100% in the last 12 months.

TherapeuticsMD saw positive EPS revisions and negative EPS revisions in the last 90 days. See TherapeuticsMD's stock price’s past reactions to earnings here.

According to InvestingPro, TherapeuticsMD's Financial Health score is "great performance".

Check out TherapeuticsMD's recent earnings performance , and TherapeuticsMD's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100